Subscribe to RSS - consent decree

consent decree

Invacare can resume design activities

 - 
04/18/2017

ELYRIA, Ohio – Invacare has been given the green light to resume design activities, according to a Form 8-K filed with the Securities and Exchange Commission.

Invacare shifts into phase two of transformation

 - 
02/10/2017

ELYRIA, Ohio – 2016 was the year Invacare tore itself down and 2017 will be the year it starts building itself back up, Matt Monaghan said during a conference call Feb. 9 to discuss the company’s fourth quarter and year-end financial results.

Invacare earnings show signs of ‘re-orientation’

 - 
02/09/2017

ELYRIA, Ohio – Invacare has reported net sales of $264.7 million for the fourth quarter of 2016 compared to $283.3 million for the same period in 2015. It reported net losses of $17.6 million vs. $2.93 million.

Change of focus drives improvements at Invacare

‘We are really not about the consent decree,’ top exec tells investors
 - 
08/05/2016

ELYRIA, Ohio – Invacare is holding tight to an improvement in gross margin for its beleaguered North America HME division as a sign that its turnaround efforts are paying off.

Invacare readies to submit final report to FDA

 - 
02/12/2016

ELYRIA, Ohio – Invacare could be turning the corner on its “ongoing journey” to lift a consent decree with the Food and Drug Administration that has handicapped the company since late 2012.

Invacare auditor submits third report

 - 
02/11/2016

ELYRIA, Ohio – Invacare’s independent auditor this week issued its certification report for the third phase of the consent decree indicating substantial compliance to the FDA’s quality system regulation.

Invacare receives feedback from FDA

 - 
12/18/2015

ELYRIA, Ohio – Invacare has received observations from the FDA following an inspection of its corporate headquarters and Taylor Street manufacturing facility.

Invacare ends year with losses

 - 
02/05/2015

ELYRIA, Ohio – Invacare reported a net loss of $9.39 million for the fourth quarter ended Dec. 31, 2014, compared to a net loss of $5.77 million for the same period in 2013.

The company reported net sales of $318.2 million vs. $330.8 million.

Invacare puts ‘turnaround plan’ in motion

 - 
08/22/2014

ELYRIA, Ohio – With a consent decree with the U.S. Food and Drug Administration (FDA) taking longer than it expected to resolve, Invacare has accelerated efforts to reduce its cost structure by reducing its workforce by 190 employees.

Invacare’s sales slump continues

 - 
02/07/2014

ELYRIA, Ohio – Invacare ended the year the same way it started—hamstrung by a consent decree with the U.S. Food and Drug Administration (FDA) that has limited manufacturing at its Taylor Street facility.

Pages